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The data published by Teo et al.5 are also interesting.
This publication elegantly illustrates potential ethnic
differences within Asian populations. In the same way, we
have suggested that ethnicity factors could be different
between African Americans and Africans.4 These differences
in ethnic coefﬁcient within Asian populations are on a much
smaller scale than the Japanese (0.808) and Chinese (1.233)
coefﬁcients that are currently being applied.
Given the extensive variation in ethnic backgrounds of
patients with CKD, it may not be plausible to have a creatinine-
based equation that will accurately model muscle mass per body
surface area based on the ethnicity for every patient. Hopefully,
with incorporation of additional biomarkers to determine CKD
and CKD severity, the relative importance of race variables with
creatinine-based equations will be less. For example, an elevated
cystatin C level or albuminuria identiﬁes the subset of patients
with a creatinine-based estimated GFRo60ml/min per 1.73m2
at risk for morbidity and mortality.6 Misclassiﬁcation with
creatinine-based equations due to inaccurate modeling of
muscle mass may be compensated by the use of additional test
abnormalities to optimize CKD classiﬁcation and staging.
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The hypothesis that type of
species change depends on
neutral-pH PD solutions
To the Editor: Peritonitis remains a common clinical
problem for patients on peritoneal dialysis (PD). Srivastava
et al.1 conducted a randomized controlled study comparing
the use of biocompatible and conventional solutions, and
concluded that techniques using biocompatible PD solutions
had clinically signiﬁcant advantages in survival of peritonitis
patients. We hypothesized that the type of species causing
PD peritonitis would change depending on neutral-pH PD
solutions.
In Japan, we have used neutral-pH PD solutions since
April 2005. Thus, we examined the type of species causing PD
peritonitis and evaluated these factors at Jikei Hospital before
and after April 2005. As Srivastava et al. reported, there was
no signiﬁcant difference in peritonitis-free survival between
using conventional and neutral-pH PD solutions (144 months
vs. 173 months NS). However, the frequency of peritonitis
caused by Gram-negative bacilli increased signiﬁcantly after
April 2005 ( from 10.7% to 33.3%, P¼ 0.02). The frequency
of peritonitis caused by Streptococcus species also increased
(from 12.5% to 33.3%, P¼ 0.05). On the other hand, the
frequency of peritonitis caused by Staphylococcus species did
not change (Figure 1).
These results might indicate that the type of species
causing PD peritonitis changes depending on neutral-pH PD
solutions. It might thus be advisable to change the selection of
antibiotics depending on PD solutions.
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Figure 1 | The frequency of the type of species causing peritoneal dialysis (PD) peritonitis between before April 2005 and after.
The differences of the type of species causing PD peritonitis before and after using neutral-pH PD solutions. The frequency of peritonitis
caused by Gram-negative bacilli increased significantly after April 2005 (from 10.7% to 33.3%, P¼ 0.02). The frequency of peritonitis
caused by Streptococcus species also increased (from 12.5% to 33.3%, P¼ 0.05). GNR, Gram-negative rod.
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The Authors Reply: We appreciate the comments by Nakao
et al.1 in response to our publication.2 In keeping with our
results, their historical control study did not find any
reduction of peritonitis rate after the introduction of
biocompatible solutions. But, the most outstanding aspect
to their report is the fact that their peritonitis rate was
between 1 in 144 and 1 in 173 patient-months! With such
excellent results, it is perhaps unrealistic to expect further
reduction in peritonitis rate. Moreover, it is unclear from
their letter whether all prevalent patients were switched to
biocompatible solutions after April 2005 or whether only new
incident patients were started on the newer solutions. If the
latter is true, then an immediate reduction in overall
peritonitis rate cannot be expected.
However, their ﬁnding of the bacterial species causing
peritonitis change is intriguing. It raises several possibilities.
Such a change may be unrelated to the introduction of
biocompatible solutions; perhaps, there were other changes
in clinical practice over the years. Equally, it is possible that
they have noticed a change in the organisms causing
peritonitis because of their very low infection rate—in our
study, any impact of biocompatible solutions may have been
overwhelmed by the high ‘bacterial burden’ experienced by
our patients. To address this possibility, we have reanalyzed
our data but selecting only patients with low risk of
peritonitis.
We somewhat arbitrarily deﬁned low-risk patients to be
aged o55 years, non-diabetic, and non-HIV. These patients
had a peritonitis rate of 1 in 37.7 vs. 1 in 40.0 patient-months
(standard vs. conventional, P¼ nonsigniﬁcant by w2). How-
ever, the proportion of patients with Gram-positive peritonitis
was higher in the biocompatible group (30 out of 41
infections) than in the standard group (15 in 31 infections).
This would appear to have reached statistical signiﬁcance
(P¼ 0.03 by w2). However, this was not a prespeciﬁed
secondary end point, and achieving a P-value of o0.05 after
multiple analysis of data is unlikely to be signiﬁcant.
Moreover, Nakao found the opposite, i.e., after biocompatible
solutions were introduced, they found that peritonitis from
Gram-negative organisms increased.
Perhaps, we can only safely conclude that we must be
cautious when interpreting historical-controlled studies or
when performing multiple non-prespeciﬁed analyses of data.
One hopes that the large multicenter Australian/New
Zealand/South East Asia balANZ study that has been pre-
sented, but not yet published, will provide a more deﬁnitive
answer to the hypothesis raised by Nakao et al.1
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